psoriasis Archives - Pharmaphorum

Novartis ups 2019 guidance after strong Q2

https://pharmaphorum.com/news/novartis-ups-2019-guidance-after-strong-q2/

BMS will shed Otezla to push Celgene takeover through

https://pharmaphorum.com/news/bms-will-shed-otezla-to-push-celgene-takeover-through/

Patient Insights: Severe psoriasis & eczema

https://pharmaphorum.com/views-analysis-patients/patient-insights-severe-psoriasis-eczema/

AbbVie gets crucial US approval for psoriasis drug Skyrizi

https://pharmaphorum.com/news/abbvie-gets-crucial-us-approval-for-psoriasis-drug-skyrizi/

AbbVie’s psoriasis drug Skyrizi approved in Japan

https://pharmaphorum.com/news/abbvies-psoriasis-drug-skyrizi-approved-in-japan/

Novartis makes quality of life case for Cosentyx with new data

https://pharmaphorum.com/news/novartis-makes-quality-of-life-case-for-cosentyx-with-new-data/

J&J’s Tremfya outperforms Novartis’ Cosentyx in psoriasis

https://pharmaphorum.com/news/jjs-tremfya-outperforms-novartis-cosentyx-in-psoriasis/

https://pharmaphorum.com/news/nice-okays-ucbs-cimzia-nixes-almirall-ilumetri-in-psoriasis/

https://pharmaphorum.com/news/jj-trumpets-new-data-from-tremfya-as-psoriasis-market-braces-for-biosimilars/

Search